Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shamir Geller

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
The Journal of Investigative Dermatology|June 30, 2025
Cutaneous T-Cell Lymphoma after Dupilumab Treatment in Patients with Atopic Dermatitis: A Response Letter to James et alShamir Geller
Journal of the American Academy of Dermatology|March 18, 2020
Interleukin 4 and interleukin 13 inhibition: A promising therapeutic approach in bullous pemphigoidShamir Geller
Frontiers in Immunology|October 23, 2023
Advances in the treatment of mycoses fungoides and Sézary syndrome: a narrative update in skin-directed therapies and immune-based treatmentsRobert Stuver, Shamir Geller
American Journal of Clinical Dermatology|May 26, 2025
Cutaneous T Cell Lymphoma Following Dupilumab Therapy in Patients with Atopic Dermatitis: Clinical Review and RecommendationsLeore Lavin, Shamir Geller
Cutis|July 1, 2020
Topical clobetasol propionate treatment and cutaneous adverse effects in patients with early-stage mycosis fungoides: an observational studyShamir Geller, Patricia L Myskowski
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 8, 2020
Fingerprint loss in two patients with Sézary syndrome: clinical and dermatoscopic evaluationShamir Geller, Patricia L Myskowski
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 28, 2020
Shamir Geller, Patricia L Myskowski
The Journal of Dermatology|April 27, 2022
Severe cutaneous adverse reactions associated with systemic ivermectin: A pharmacovigilance analysisDavid Bomze, Eli Sprecher, Shamir Geller
Skin Health and Disease|April 4, 2023
Skin cancer special issue in Skin Health and DiseaseOriol Yélamos, Shamir Geller, Selin Tokez
The Journal of Investigative Dermatology|June 30, 2024
Cutaneous T-Cell Lymphoma after Dupilumab Use: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting SystemLeore Lavin, Stephen Dusza, Shamir Geller
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
The Journal of Investigative Dermatology|June 30, 2025
Cutaneous T-Cell Lymphoma after Dupilumab Treatment in Patients with Atopic Dermatitis: A Response Letter to James et alShamir Geller
Journal of the American Academy of Dermatology|March 18, 2020
Interleukin 4 and interleukin 13 inhibition: A promising therapeutic approach in bullous pemphigoidShamir Geller
Frontiers in Immunology|October 23, 2023
Advances in the treatment of mycoses fungoides and Sézary syndrome: a narrative update in skin-directed therapies and immune-based treatmentsRobert Stuver, Shamir Geller
American Journal of Clinical Dermatology|May 26, 2025
Cutaneous T Cell Lymphoma Following Dupilumab Therapy in Patients with Atopic Dermatitis: Clinical Review and RecommendationsLeore Lavin, Shamir Geller
Cutis|July 1, 2020
Topical clobetasol propionate treatment and cutaneous adverse effects in patients with early-stage mycosis fungoides: an observational studyShamir Geller, Patricia L Myskowski
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 8, 2020
Fingerprint loss in two patients with Sézary syndrome: clinical and dermatoscopic evaluationShamir Geller, Patricia L Myskowski
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 28, 2020
Shamir Geller, Patricia L Myskowski
The Journal of Dermatology|April 27, 2022
Severe cutaneous adverse reactions associated with systemic ivermectin: A pharmacovigilance analysisDavid Bomze, Eli Sprecher, Shamir Geller
Skin Health and Disease|April 4, 2023
Skin cancer special issue in Skin Health and DiseaseOriol Yélamos, Shamir Geller, Selin Tokez
The Journal of Investigative Dermatology|June 30, 2024
Cutaneous T-Cell Lymphoma after Dupilumab Use: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting SystemLeore Lavin, Stephen Dusza, Shamir Geller
Pageof 7